AFLAC Incorporated with ticker code (AFL) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 70 and 52 with the average target price sitting at 62.15. Now with the previous closing price of 64.49 this indicates there is a potential downside of -3.6%. The 50 day MA is 62.6 while the 200 day moving average is 57.3. The market capitalisation for the company is $42,553m. Company Website: https://www.aflac.com
The potential market cap would be $41,009m based on the market concensus.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
